When will xarelto become a generic drug?

Xarelto (rivaroxaban) becoming generic depends on patent status and regulatory exclusivities, which vary by country. There isn’t a single universal date.

- In the United States: rivaroxaban is protected by multiple patents and potential exclusivities. Generics would typically enter after the last relevant patent/exclusivity expires, plus any settlements with brand-name manufacturers. The general expectation has been that entry could occur in the mid-2020s to late-2020s, but exact timing depends on patent litigation and settlements.

- In Europe and other markets: some patents may have expired earlier or later depending on the country, so generic rivaroxaban could appear sooner in some places.

If you’d like, tell me your country (or the region you’re in). I can look up the latest patent/exclusivity status and give you a more precise estimate for that market.

In the meantime:
- You can check the FDA’s Orange Book for the US (patent and exclusivity status for rivaroxaban).
- Check EMA/your national regulator’s patent status for Europe.
- Talk to a pharmacist or your doctor about pricing and any approved generic alternatives in your area.